← FDA Drug Approvals (Drugs@FDA)

PREGABALIN

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: TORRENT · Approved 2025-02-21

Drug application

FDA Application #
ANDA206942
Application type
Abbreviated New Drug Application (Generic)
Brand name
PREGABALIN
Generic name
PREGABALIN
Active ingredients
PREGABALIN
Dosage form
CAPSULE
Route
ORAL
Marketing status
Prescription
Sponsor
TORRENT
Manufacturer
Torrent Pharmaceuticals Limited
First approval
2025-02-21

Source

Authoritative
Drugs@FDA application overview
Machine
JSON-LD · Markdown